Sun Pharmaceutical Industries Limited
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (54)
Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
Started: 5/13/2021
A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
Started: 3/21/2025
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)
Started: 7/1/2020
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Started: 6/30/2022
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
Started: 7/1/2020
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Started: 12/20/2021
Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
Started: 3/29/2019
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Started: 2/1/2016
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Started: 12/6/2012
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)
Started: 2/5/2013
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)
Started: 9/1/2013
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
Started: 11/1/2015
Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis
Started: 10/1/2011
An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Started: 7/29/2016
Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects
Started: 3/30/2018
2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery
Started: 1/3/2018
Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects
Started: 7/1/2012
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Started: 5/1/2013
Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery
Started: 1/30/2018
A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension
Started: 6/10/2019
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
Started: 9/22/2018
Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
Started: 3/1/2013
Efficacy and Safety Of Spil's Estradiol Vaginal Tablet
Started: 11/6/2012
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Started: 1/20/2026
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Started: 8/31/2022
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
Started: 1/15/2020
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Started: 3/25/2021
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
Started: 7/30/2021
Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
Started: 7/11/2018
Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis
Started: 12/22/2020
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Started: 9/1/2014
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer
Started: 3/21/2016
Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery
Started: 7/1/2011
A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Started: 1/1/2018
One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™
Started: 11/1/2016
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis
Started: 1/1/2017
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
Started: 7/24/2017
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
Started: 2/25/2026
An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face
Started: 8/4/2026
Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers
Started: 8/1/2010
Pharmacokinetic and Pharmacodynamic Study of Cyclofem
Started: 6/1/2010
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
Started: 7/1/2024
A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
Started: 9/1/2023
A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
Started: 11/15/2023
A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
Started: 11/15/2023
A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients
Started: 2/14/2024
A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients
Started: 11/27/2023
A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis
Started: 7/16/2019
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
Started: 3/21/2017
ABSORICA in Patients With Severe Recalcitrant Nodular Acne
Started: 1/21/2015